ViAqua Therapeutics logo

ViAqua Therapeutics

Recent Finacing

Equity

Recent Raise

$8.3M


ViAqua Therapeutics is a biotechnology company that develops RNA-based, nucleic acid solutions for disease management in aquaculture, with their initial product being a feed supplement that enhances resistance to viral infections in shrimp.

Total Funding

$8.3M

Headquarters

Haifa, Israel

Founded

N/A

Focus Areas

Biotechnology
Aquaculture
Disease Management

Investors